---
title: Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant
  Ovarian Cancer
date: '2023-08-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37568590/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230812180946&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Overcoming PARPi resistance is a high clinical priority. We established
  and characterized comparative in vitro models of acquired PARPi resistance, derived
  from either a BRCA1-proficient or BRCA1-deficient isogenic background by long-term
  exposure to olaparib. While parental cell lines already exhibited a certain level
  of intrinsic activity of multidrug resistance (MDR) proteins, resulting PARPi-resistant
  cells from both models further converted toward MDR. In both models, the ...
disable_comments: true
---
Overcoming PARPi resistance is a high clinical priority. We established and characterized comparative in vitro models of acquired PARPi resistance, derived from either a BRCA1-proficient or BRCA1-deficient isogenic background by long-term exposure to olaparib. While parental cell lines already exhibited a certain level of intrinsic activity of multidrug resistance (MDR) proteins, resulting PARPi-resistant cells from both models further converted toward MDR. In both models, the ...